One of Uptown Dallas' most recognizable addresses just locked in a hefty new loan. Crescent Real Estate, led by John Goff, has refinanced a big chunk of its namesake complex, The Crescent, with a $596 million, three-year floating-rate CMBS facility. The debt was placed through Goldman Sachs and J.P. Morgan and arranged by JLL, following Crescent's re-acquisition of the property in 2021 and ongoing efforts to revamp its mix of retail and office space.
JLL's Capital Markets team said the new financing covers the three office towers and the connected atrium building, totaling roughly 1.3 million square feet of offices, retail, and restaurants, and that the asset is about 90% leased to major financial and corporate tenants. JLL arranged the financing on behalf of Crescent and confirmed that the loan is a three-year, floating-rate CMBS facility placed through Goldman Sachs and J.P. Morgan, according to JLL.
Loan structure and refinancing risk
The short, three-year term gives Crescent quick access to large-bank capital but also means the company will be back in the market for new debt before long. Industry reports point to a wave of commercial debt maturities between 2026 and 2027, which makes short-term, floating-rate CMBS structures more exposed to shifts in interest rates and underwriting standards. That could complicate future rollovers, as noted by Sterling Asset Group.
Why Uptown still draws capital
The Crescent sits on an 11-acre parcel anchored by the luxury Hotel Crescent Court and a cluster of high-end retail and dining spots that have helped keep occupancy strong. Crescent's own materials note that the firm re-acquired the complex in 2021 and describe the property's blend of trophy offices, hotel space, and upscale retail, according to Crescent Real Estate. The refinancing deal was announced this week, as reported by Dallas Business Journal.
For Crescent, the refinancing delivers immediate liquidity backed by two major banks, while also setting up another capital event when the loan reaches maturity. The move comes on the heels of Crescent's recent closing of GP Invitation Fund IV in late 2025, which provided fresh capital for its office portfolio, per The Real Deal.
